15:52 Feb 04

Torrent Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
4023.50
-22.10 (-0.55%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Torrent Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
4023.50
-22.10 (-0.55%)
15:52 Feb 04
Quality
image/svg+xml

97/100
High Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

61/100
Technically Moderately Bullish

Strength

0

Weakness

0

Opportunity

0

Threats

0

25.17 %

ROE %

12.75 %

ROA %

0.00

EPS

224.27

BVPS

16.59 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
8004.57 8508.04 9620.15 10727.84 11516.09
Operating Expenses +
5524.49 6076.77 6778.1 7360.19 7795.1
Raw Material
2425.66 2368.15 2569 2841.22 3050.82
Increase Decrease in Cost
-279.24 73.86 166.19 -155.01 -274.92
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1439.62 1526.45 1677.69 1984.4 2203.37
Miscellaneous Expenses
3948.39 3769.61 4542.38 5056.84 5876.83
Operating Profit
2480.08 2431.27 2842.05 3367.65 3720.99
Other Income
56.91 196.56 45.14 57.91 23.27
Depreciation
657.79 662.16 706.59 808.27 794.93
Interest
352.94 255.06 333.44 353.56 252.31
Profit before tax and exceptio..
1526.26 1710.61 1847.16 2263.73 2697.02
Exceptional Items
0 -484.7 0 88.38 -24.21
PBT
1526.26 1225.91 1847.16 2352.11 2672.81
Provision for Taxation
274.38 448.73 601.93 695.73 761.56
Net Profit
1251.88 777.18 1245.23 1656.38 1911.25
NET Profit after MI
1251.88 777.18 1245.23 1656.38 1911.25
EPS
73.98 45.93 36.79 48.94 56.47
Operating Profit Margin (%)
30.98 28.58 29.54 31.39 32.31
Net Profit Margin (%)
15.64 9.13 12.94 15.44 16.6

Torrent Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 68.30 68.30 68.30 68.30 68.30 71.20
FII 16.10 15.90 16.10 16.30 16.20 14.50
Public 9.20 9.30 8.60 8.40 8.30 7.00
Others 6.40 6.50 7.00 7.00 7.20 7.30
Shareholder Shares Holding %
Download Our App On: